No abstract available
MeSH terms
-
Anti-Infective Agents / adverse effects
-
Anti-Infective Agents / therapeutic use
-
Aza Compounds*
-
Cost of Illness
-
Female
-
Fluoroquinolones*
-
Humans
-
Lung Diseases, Obstructive / drug therapy
-
Lung Diseases, Obstructive / economics
-
Lung Diseases, Obstructive / etiology
-
Lung Diseases, Obstructive / physiopathology*
-
Male
-
Moxifloxacin
-
Quinolines*
-
Smoking / adverse effects
Substances
-
Anti-Infective Agents
-
Aza Compounds
-
Fluoroquinolones
-
Quinolines
-
Moxifloxacin